When tumor cells evade T-cell-mediated immune killing by over-expressing programmed cell death protein ligand 1 (PD-L1), they form immune escape by binding to immune checkpoints to disengage the receptor-ligand interaction between tumor cells and T cells (Renkvist et al., 2001). The gene discussed is CD274; the disease is neoplasm.